John Thomas O'Malley, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Prurigo | 2 | 2024 | 25 | 1.070 |
Why?
|
Mycosis Fungoides | 4 | 2023 | 170 | 1.040 |
Why?
|
Dermatitis, Atopic | 8 | 2023 | 731 | 0.920 |
Why?
|
STAT4 Transcription Factor | 6 | 2009 | 94 | 0.900 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 3 | 2019 | 212 | 0.710 |
Why?
|
Skin | 11 | 2022 | 4473 | 0.690 |
Why?
|
Histiocytosis, Non-Langerhans-Cell | 1 | 2018 | 22 | 0.610 |
Why?
|
T-Lymphocyte Subsets | 4 | 2022 | 1803 | 0.570 |
Why?
|
Dermatitis | 1 | 2019 | 202 | 0.550 |
Why?
|
Heavy Chain Disease | 1 | 2014 | 19 | 0.480 |
Why?
|
Elastic Tissue | 1 | 2014 | 66 | 0.470 |
Why?
|
Cutis Laxa | 1 | 2014 | 29 | 0.470 |
Why?
|
Arthralgia | 1 | 2018 | 461 | 0.450 |
Why?
|
Congresses as Topic | 1 | 2019 | 803 | 0.450 |
Why?
|
Th1 Cells | 4 | 2016 | 1042 | 0.410 |
Why?
|
Radiotherapy | 1 | 2019 | 1498 | 0.410 |
Why?
|
Hyperpigmentation | 1 | 2013 | 116 | 0.380 |
Why?
|
Skin Pigmentation | 1 | 2013 | 277 | 0.360 |
Why?
|
Skin Neoplasms | 6 | 2023 | 5809 | 0.340 |
Why?
|
Immunologic Memory | 4 | 2022 | 1361 | 0.320 |
Why?
|
Severity of Illness Index | 10 | 2023 | 15845 | 0.260 |
Why?
|
Health Status | 1 | 2019 | 4077 | 0.250 |
Why?
|
Injections, Subcutaneous | 2 | 2023 | 672 | 0.240 |
Why?
|
Interleukin-17 | 6 | 2020 | 913 | 0.220 |
Why?
|
Skin Diseases | 3 | 2020 | 1095 | 0.200 |
Why?
|
Double-Blind Method | 7 | 2023 | 12341 | 0.190 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2019 | 9278 | 0.190 |
Why?
|
Th17 Cells | 2 | 2017 | 794 | 0.180 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 2 | 2019 | 346 | 0.170 |
Why?
|
Interleukin-12 | 4 | 2009 | 578 | 0.170 |
Why?
|
Inflammation Mediators | 1 | 2008 | 1885 | 0.170 |
Why?
|
Pruritus | 1 | 2023 | 378 | 0.170 |
Why?
|
T-Lymphocytes, Regulatory | 3 | 2016 | 3092 | 0.170 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2023 | 4574 | 0.160 |
Why?
|
Eczema | 1 | 2021 | 246 | 0.160 |
Why?
|
Dermatologic Agents | 1 | 2022 | 313 | 0.150 |
Why?
|
Genes, T-Cell Receptor beta | 1 | 2018 | 70 | 0.150 |
Why?
|
STAT3 Transcription Factor | 2 | 2016 | 872 | 0.150 |
Why?
|
Monitoring, Immunologic | 1 | 2018 | 99 | 0.150 |
Why?
|
Lymphomatoid Papulosis | 1 | 2017 | 16 | 0.140 |
Why?
|
STAT6 Transcription Factor | 2 | 2007 | 196 | 0.140 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2018 | 3634 | 0.130 |
Why?
|
Interleukin-9 | 1 | 2016 | 62 | 0.130 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2017 | 391 | 0.120 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 1 | 2017 | 168 | 0.120 |
Why?
|
STAT5 Transcription Factor | 1 | 2016 | 266 | 0.120 |
Why?
|
Candidiasis | 1 | 2017 | 365 | 0.120 |
Why?
|
Stevens-Johnson Syndrome | 1 | 2017 | 246 | 0.120 |
Why?
|
Treatment Outcome | 10 | 2023 | 64670 | 0.120 |
Why?
|
Candida albicans | 1 | 2017 | 372 | 0.120 |
Why?
|
T-Lymphocytes | 4 | 2020 | 10203 | 0.120 |
Why?
|
Interferon-gamma | 4 | 2020 | 3155 | 0.120 |
Why?
|
Interferon Regulatory Factors | 1 | 2016 | 261 | 0.120 |
Why?
|
Deafness | 1 | 2018 | 459 | 0.110 |
Why?
|
Nerve Degeneration | 1 | 2018 | 747 | 0.110 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2008 | 2423 | 0.110 |
Why?
|
Myeloproliferative Disorders | 1 | 2020 | 609 | 0.110 |
Why?
|
Pain Measurement | 1 | 2024 | 3548 | 0.110 |
Why?
|
Facial Transplantation | 1 | 2016 | 222 | 0.110 |
Why?
|
Cytokines | 1 | 2008 | 7386 | 0.110 |
Why?
|
Internationality | 1 | 2019 | 1000 | 0.110 |
Why?
|
Arthritis | 1 | 2018 | 681 | 0.100 |
Why?
|
Psoriasis | 2 | 2017 | 945 | 0.100 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2018 | 781 | 0.100 |
Why?
|
Cochlea | 1 | 2018 | 844 | 0.100 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1878 | 0.090 |
Why?
|
Microscopy, Electron | 1 | 2014 | 2562 | 0.090 |
Why?
|
Forkhead Transcription Factors | 2 | 2009 | 1612 | 0.090 |
Why?
|
Humans | 32 | 2024 | 761098 | 0.090 |
Why?
|
Influenza Vaccines | 1 | 2017 | 767 | 0.090 |
Why?
|
Mice, SCID | 2 | 2020 | 2621 | 0.080 |
Why?
|
Adult | 12 | 2024 | 221083 | 0.080 |
Why?
|
Neoplasms, Second Primary | 1 | 2017 | 1051 | 0.080 |
Why?
|
Dendritic Cells | 1 | 2020 | 2726 | 0.080 |
Why?
|
Immunoglobulin A | 2 | 2022 | 978 | 0.080 |
Why?
|
Cells, Cultured | 4 | 2017 | 18926 | 0.080 |
Why?
|
Lipid Metabolism | 1 | 2017 | 1893 | 0.080 |
Why?
|
Transforming Growth Factor beta1 | 2 | 2009 | 630 | 0.080 |
Why?
|
Survival Rate | 2 | 2019 | 12727 | 0.080 |
Why?
|
Chronic Disease | 1 | 2023 | 9317 | 0.070 |
Why?
|
Female | 16 | 2024 | 392458 | 0.070 |
Why?
|
Mice | 13 | 2022 | 81324 | 0.070 |
Why?
|
Graft vs Host Disease | 1 | 2020 | 3026 | 0.070 |
Why?
|
Respiratory Hypersensitivity | 1 | 2009 | 271 | 0.070 |
Why?
|
Lymphocyte Transfusion | 1 | 2008 | 232 | 0.070 |
Why?
|
Sequence Deletion | 2 | 2008 | 1487 | 0.070 |
Why?
|
Biopsy | 2 | 2020 | 6781 | 0.070 |
Why?
|
Protein Isoforms | 2 | 2008 | 1696 | 0.070 |
Why?
|
Carcinoma, Basal Cell | 1 | 2012 | 557 | 0.070 |
Why?
|
Mice, Inbred C57BL | 5 | 2017 | 22129 | 0.070 |
Why?
|
Immunity, Innate | 1 | 2019 | 3044 | 0.070 |
Why?
|
Middle Aged | 9 | 2024 | 220835 | 0.070 |
Why?
|
Influenza, Human | 1 | 2017 | 1521 | 0.070 |
Why?
|
HIV Infections | 1 | 2013 | 17349 | 0.070 |
Why?
|
Diagnosis, Differential | 2 | 2020 | 12975 | 0.070 |
Why?
|
Boston | 1 | 2019 | 9324 | 0.060 |
Why?
|
Tumor Suppressor Proteins | 1 | 2016 | 2802 | 0.060 |
Why?
|
Male | 14 | 2024 | 360675 | 0.060 |
Why?
|
Lymphocyte Activation | 3 | 2016 | 5478 | 0.060 |
Why?
|
Graft Survival | 1 | 2016 | 3841 | 0.060 |
Why?
|
Virion | 1 | 2007 | 422 | 0.060 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2017 | 2549 | 0.060 |
Why?
|
Lower Extremity | 1 | 2013 | 1201 | 0.060 |
Why?
|
Lymphoproliferative Disorders | 1 | 2007 | 530 | 0.060 |
Why?
|
DNA, Complementary | 1 | 2007 | 1989 | 0.060 |
Why?
|
Protein Engineering | 1 | 2007 | 548 | 0.050 |
Why?
|
Cell Lineage | 2 | 2009 | 2547 | 0.050 |
Why?
|
Animals | 13 | 2022 | 168083 | 0.050 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2008 | 826 | 0.050 |
Why?
|
Graft Rejection | 1 | 2016 | 4479 | 0.050 |
Why?
|
Transcriptional Activation | 1 | 2008 | 1751 | 0.050 |
Why?
|
Quality of Life | 1 | 2024 | 13362 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2020 | 5667 | 0.050 |
Why?
|
Protein Structure, Tertiary | 1 | 2008 | 3779 | 0.050 |
Why?
|
Adolescent | 5 | 2022 | 88271 | 0.050 |
Why?
|
Germany | 1 | 2023 | 872 | 0.050 |
Why?
|
Prospective Studies | 3 | 2020 | 54419 | 0.050 |
Why?
|
Gene Expression Regulation | 2 | 2009 | 11856 | 0.050 |
Why?
|
Gene Regulatory Networks | 1 | 2009 | 1744 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2023 | 13630 | 0.040 |
Why?
|
Disease Susceptibility | 1 | 2007 | 1790 | 0.040 |
Why?
|
Mice, Inbred BALB C | 1 | 2009 | 6198 | 0.040 |
Why?
|
Phototherapy | 1 | 2023 | 368 | 0.040 |
Why?
|
Hepacivirus | 1 | 2007 | 1330 | 0.040 |
Why?
|
Cell Differentiation | 3 | 2017 | 11505 | 0.040 |
Why?
|
Up-Regulation | 1 | 2008 | 4111 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2019 | 58946 | 0.040 |
Why?
|
Mice, Transgenic | 2 | 2008 | 9518 | 0.040 |
Why?
|
Presbycusis | 1 | 2018 | 43 | 0.040 |
Why?
|
Administration, Topical | 1 | 2020 | 703 | 0.040 |
Why?
|
Foreskin | 1 | 2018 | 33 | 0.040 |
Why?
|
Receptors, Lymphocyte Homing | 1 | 2018 | 141 | 0.040 |
Why?
|
Hearing Tests | 1 | 2018 | 121 | 0.040 |
Why?
|
Influenza B virus | 1 | 2017 | 50 | 0.040 |
Why?
|
Laboratories | 1 | 2021 | 462 | 0.040 |
Why?
|
Immunocompetence | 1 | 2017 | 138 | 0.040 |
Why?
|
Recombinant Proteins | 1 | 2007 | 6507 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2008 | 4340 | 0.040 |
Why?
|
Evoked Potentials, Auditory, Brain Stem | 1 | 2018 | 253 | 0.030 |
Why?
|
Weight Loss | 1 | 2008 | 2680 | 0.030 |
Why?
|
Antigen-Presenting Cells | 1 | 2020 | 965 | 0.030 |
Why?
|
Auditory Threshold | 1 | 2018 | 369 | 0.030 |
Why?
|
Hair Cells, Auditory, Inner | 1 | 2018 | 197 | 0.030 |
Why?
|
Vaccinia | 1 | 2017 | 70 | 0.030 |
Why?
|
Cell Survival | 2 | 2017 | 5776 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2008 | 14393 | 0.030 |
Why?
|
Interleukin-23 | 2 | 2008 | 201 | 0.030 |
Why?
|
Noise | 1 | 2018 | 290 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2020 | 1822 | 0.030 |
Why?
|
China | 1 | 2021 | 2374 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2017 | 18217 | 0.030 |
Why?
|
Vaccinia virus | 1 | 2017 | 329 | 0.030 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2017 | 295 | 0.030 |
Why?
|
Clone Cells | 1 | 2018 | 1667 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2022 | 1086 | 0.030 |
Why?
|
Drug Combinations | 1 | 2020 | 2048 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2017 | 800 | 0.030 |
Why?
|
Kidney Function Tests | 1 | 2016 | 680 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 2016 | 781 | 0.030 |
Why?
|
Multiple Sclerosis | 1 | 2008 | 3222 | 0.030 |
Why?
|
Prognosis | 3 | 2020 | 29672 | 0.030 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2017 | 668 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2022 | 2160 | 0.030 |
Why?
|
Child | 4 | 2022 | 80134 | 0.030 |
Why?
|
Young Adult | 1 | 2019 | 59199 | 0.030 |
Why?
|
Adaptive Immunity | 1 | 2017 | 724 | 0.030 |
Why?
|
Age Distribution | 1 | 2018 | 2873 | 0.030 |
Why?
|
Biological Transport | 1 | 2017 | 2082 | 0.030 |
Why?
|
Amino Acid Sequence | 2 | 2017 | 13404 | 0.020 |
Why?
|
Aged | 3 | 2019 | 169266 | 0.020 |
Why?
|
Kidney | 1 | 2007 | 7034 | 0.020 |
Why?
|
Whole-Body Irradiation | 1 | 2012 | 432 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2017 | 2227 | 0.020 |
Why?
|
Gene Expression | 1 | 2023 | 7567 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2019 | 80673 | 0.020 |
Why?
|
Anemia, Aplastic | 1 | 2012 | 230 | 0.020 |
Why?
|
Disease Management | 1 | 2020 | 2508 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2016 | 1837 | 0.020 |
Why?
|
Pain | 1 | 2024 | 5070 | 0.020 |
Why?
|
Sleep | 1 | 2024 | 4761 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 2270 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2018 | 26187 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2016 | 2181 | 0.020 |
Why?
|
RNA Interference | 1 | 2016 | 2816 | 0.020 |
Why?
|
Hemagglutinins | 1 | 2007 | 111 | 0.020 |
Why?
|
Splenomegaly | 1 | 2007 | 191 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2016 | 3409 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2023 | 9185 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2017 | 6817 | 0.020 |
Why?
|
Base Sequence | 1 | 2017 | 12404 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2018 | 3461 | 0.020 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2007 | 307 | 0.020 |
Why?
|
Cell Movement | 1 | 2017 | 5195 | 0.020 |
Why?
|
Interleukin-18 | 1 | 2007 | 250 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2017 | 3048 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2017 | 3594 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12058 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2012 | 2692 | 0.010 |
Why?
|
Inflammation | 2 | 2018 | 10758 | 0.010 |
Why?
|
Interleukin-10 | 1 | 2008 | 1176 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2018 | 8529 | 0.010 |
Why?
|
Antigens | 1 | 2007 | 1441 | 0.010 |
Why?
|
Spleen | 1 | 2007 | 2290 | 0.010 |
Why?
|
Glycoproteins | 1 | 2008 | 2203 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2016 | 10421 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2017 | 22157 | 0.010 |
Why?
|
Risk Factors | 2 | 2017 | 74219 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2016 | 16947 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 41486 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2007 | 3388 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2007 | 3210 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2008 | 5103 | 0.010 |
Why?
|
Child, Preschool | 1 | 2017 | 42217 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2016 | 39121 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2009 | 12743 | 0.010 |
Why?
|
United States | 1 | 2022 | 72337 | 0.010 |
Why?
|
Cell Line | 1 | 2007 | 15542 | 0.010 |
Why?
|
Time Factors | 1 | 2009 | 39953 | 0.000 |
Why?
|